Systemic Treatments for Alopecia Areata Registry
NCT06283316 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2024-02-28
Summary
A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.
Conditions
- Alopecia Areata
- Alopecia Totalis
- Alopecia Universalis
- Hair Loss
- Hair Diseases
- Alopecia
- Alopecia Drugs
- Autoimmune Diseases
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-17
- Primary Completion
- 2099-12-31
- Completion
- 2099-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors
NCT05588310 ·Status: UNKNOWN
-
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
NCT05865041 ·Status: RECRUITING ·Phase: PHASE2
-
a Retrospective Study on the Systemic Treatment of LPP and FFA
NCT06512766 ·Status: COMPLETED
-
Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata
NCT05910138 ·Status: UNKNOWN ·Phase: NA
-
Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata
NCT06399783 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.
NCT05599243 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
NCT02018042 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata
NCT00063076 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
NCT02974868 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
NCT05398809 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Platelet-Rich Plasma Versus Mesotherapy in Androgenetic Alopecia: A Retrospective Study
NCT05129800 ·Status: COMPLETED
-
Clinical Application of Stem Cell Educator Therapy in Alopecia Areata
NCT04011748 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings
NCT07200128 ·Status: COMPLETED
-
Stem Cell Educator Therapy in Alopecia Areata
NCT01673789 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
NCT02037191 ·Status: COMPLETED ·Phase: PHASE3
-
Excimer Light and Topical Steroid in Treatment of Alopecia Areata
NCT04793945 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
NCT03532958 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
NCT01917058 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia
NCT06558565 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
NCT07049328 ·Status: RECRUITING ·Phase: PHASE1
-
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
NCT02684123 ·Status: COMPLETED ·Phase: NA
-
Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia
NCT02848300 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
NCT01385839 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
NCT01840046 ·Status: TERMINATED ·Phase: PHASE1/PHASE2